Ulnar artery aneurysm in a patient with Behçet's disease.
Behçet's disease is a systemic disease characterized by oral aphthosis, genital ulcers, ocular lesions, gastrointestinal, musculoskeletal, neurological and major vessel involvement. Arterial involvement, aneurysms and arterial thrombosis have been reported in 1.5-3% of patients. In this case report, we present a patient with ulnar arterial aneurysm associated with Behçet's disease.
Kisacik
Bunyamin
B
Division of Rheumatology, Department of Internal Medicine, Gulhane Military School of Medicine, Etlik, 06100 Ankara, Turkey. Bunyamin_k@hotmail.com
Kasifoglu
Timucin
T
Akay
Sinan
S
Yilmaz
Omer
O
Yilmaz
Sedat
S
Simsek
Ismail
I
Erdem
Hakan
H
Pay
Salih
S
Dinc
Ayhan
A
D000783:Aneurysm / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D000792:Angiography; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006225:Hand / Q000000981:diagnostic imaging / Q000473:pathology*; D006801:Humans; D008297:Male; D019226:Oral Ulcer / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D014057:Tomography, X-Ray Computed; D014421:Turkey; D017535:Ulnar Artery / Q000000981:diagnostic imaging / Q000473:pathology*; D014463:Ultrasonography; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D003520:Cyclophosphamide; D011239:Prednisolone